Will Genome Modifications Define Next-Gen AAV Vectors?

Adeno-associated viruses (AAV) are notoriously imperfect therapeutic carriers, and experts predict that the next generation of AAV serotypes will include thoughtful, low-touch genetic modifications that transform their profiles for the better.

Arun Srivastava, Ph.D., a University of Florida College of Medicine professor and one of the pioneers of AAVs, has been speaking about what the next generation of genome-modified AAV vectors will look like, and he agreed to share some of his perspectives with us, so we sent him some questions. Here’s how he answered them.

Read more about Will Genome Modifications Define Next-Gen AAV Vectors?